The other DOACs showed a trend towards an increased risk of ischaemic stroke, though this was not statistically significant.
← all excerpts
Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study).
1
—
—